Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Treasury Shares (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Treasury Shares for 5 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 4.95% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Dec 2025, up 4.95% year-over-year, with the annual reading at $9.7 million for FY2025, 4.95% up from the prior year.
  • Treasury Shares for Q4 2025 was $9.7 million at Strata Critical Medical, down from $10.4 million in the prior quarter.
  • The five-year high for Treasury Shares was $11.5 million in Q1 2024, with the low at $1.5 million in Q3 2021.
  • Average Treasury Shares over 5 years is $7.1 million, with a median of $7.5 million recorded in 2022.
  • The sharpest move saw Treasury Shares soared 214.58% in 2022, then dropped 29.55% in 2023.
  • Over 5 years, Treasury Shares stood at $2.4 million in 2021, then skyrocketed by 214.58% to $7.5 million in 2022, then fell by 29.55% to $5.3 million in 2023, then soared by 76.54% to $9.3 million in 2024, then increased by 4.95% to $9.7 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $9.7 million, $10.4 million, and $10.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.